The Annual General Meeting of Orion Corporation was held on Thursday 25 March 2021 at Orion's Head Office in Espoo. The decisions and related material are available here.
Orion published Interim Report for January–September 2021 on Wednesday, 20 October 2021. The report and related presentation material as well as webcast recording are available here.
Orion Group's Financial Statement documents for 2020 are available here.
The product and service portfolio of Orion includes a variety of human pharmaceuticals, veterinary drugs, APIs and contract manufacturing.
Orion is the largest employer in the Finnish pharmaceutical industry. It is considered to be a good and reliable employer, which is also indicated by its lower-than-average employee turnover.
From the sustainability section you will find, among others, our Sustainability reports, Code of Conduct and Quality Policy.
